1Pharmacist, Adam’s Pharmacy, 8, Wenceslas Square 775, New Town, 110 00 Prague, Czechia.
2Lecturer, Faculty of Pharmacy, University of Tuzla, Dr. Tihomila Markovi?a 1, Tuzla Grad 75000, Bosnia and Herzegovina.
3Lecturer, Dept. of Pharmacy, Yerevan State University, 1 Alek Manukyan St, Yerevan 0025, Armenia.
4Research Scholar, Kalinga University, Kotni, Atal Nagar-Nava Raipur, Chhattisgarh 492101, India.
5Student, Bachelor of Computer Application, Kalinga University, Kotni, Atal Nagar-Nava Raipur, Chhattisgarh 492101, India.
6Assistant Professor, DmbH Institute of Medical Science, Dadpur, West Bengal 712305, India.
7Student, Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand 835219, India.
8Assistant Professor, Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand 835219, India
9Assistant Professor, Sai College of Pharmacy, Barbigha, Bihar 811101, India
The integration of artificial intelligence (AI) in healthcare has accelerated dramatically between 2023 and 2025, fundamentally transforming disease diagnosis and pharmaceutical dispensing practices. This review examines the current state and emerging trends of AI-driven healthcare technologies, focusing on diagnostic applications and automated medicine dispensing systems. Recent data indicates that physician adoption of healthcare AI increased by 78% from 2023 to 2024, with two-thirds of physicians now utilizing AI tools in their practice. The convergence of machine learning algorithms, computer vision, and robotics has created unprecedented opportunities for precision medicine, automated pharmacy operations, and enhanced patient outcomes. This paper analyses the technological advancements, clinical applications, market dynamics, and future implications of AI in healthcare delivery systems.
The healthcare landscape has witnessed a paradigm shift with the rapid adoption of artificial intelligence technologies between 2023 and 2025. This transformation encompasses two critical domains: AI-enhanced disease diagnosis and automated medicine dispensing systems. The global AI in healthcare market is experiencing unprecedented growth, with projections indicating an annual growth rate of 37.3% through 2030. This exponential expansion reflects the technology's maturation and its proven capability to address longstanding challenges in healthcare delivery. The period from 2023 to 2025 has been particularly significant, marking a transition from experimental AI applications to mainstream clinical adoption. Healthcare institutions worldwide have increasingly integrated AI-driven solutions into their diagnostic workflows and pharmaceutical operations, driven by the need for improved accuracy, efficiency, and patient safety. This review synthesizes current developments, analyses implementation patterns, and projects future trajectories in AI-driven healthcare [1-5].
2. AI in Disease Diagnosis: Current State and Advancements (2023-2025)
2.1 Diagnostic Accuracy and Clinical Integration [6-8]
The period 2023-2025 has witnessed remarkable improvements in AI diagnostic capabilities across multiple medical specialties. Machine learning algorithms now demonstrate superior performance in detecting various conditions, including infectious diseases, cancer, and cardiovascular disorders. AI systems have shown particular strength in medical imaging interpretation, pathology analysis, and pattern recognition in complex diagnostic scenarios. Recent clinical studies have demonstrated that AI can match or exceed human diagnostic accuracy in specific domains while significantly reducing diagnostic time. The technology's ability to process vast amounts of patient data, including electronic health records, laboratory results, and imaging studies, enables comprehensive diagnostic assessments that consider multiple variables simultaneously.
2.2 Physician Adoption and Workflow Integration [9-12]
Healthcare provider adoption of AI diagnostic tools has accelerated substantially. Survey data from 2024 reveals that 66% of physicians are now using healthcare AI, representing a 78% increase from 2023 levels. This rapid adoption reflects growing confidence in AI capabilities and the technology's proven ability to enhance clinical decision-making without replacing physician expertise. AI applications in diagnostic medicine currently focus on several key areas: documentation of billing codes, creation of medical charts and visit notes, development of discharge instructions and care plans, and clinical decision support. These applications have demonstrated measurable improvements in workflow efficiency and diagnostic consistency.
2.3 Emerging Technologies and Future Applications [13-15]
The diagnostic AI landscape continues to evolve with the introduction of advanced algorithms capable of multi-modal data integration. Recent developments include AI systems that can analyze patient symptoms, laboratory data, and imaging results simultaneously to provide comprehensive diagnostic recommendations. These systems are particularly valuable in complex cases where multiple differential diagnoses must be considered. Predictive analytics represents another frontier in AI diagnostics, with systems now capable of identifying patients at risk for specific conditions before symptoms manifest. This proactive approach enables early intervention and preventive care strategies that can significantly improve patient outcomes.
Table No. 1. AI in Disease Diagnosis: Developments and Clinical Integration (2023–2025)
|
Section |
Focus Area |
Key Findings |
Implications |
|
Diagnostic Accuracy and Clinical Integration |
- AI performance in disease detection |
- AI matches or exceeds human diagnostic accuracy in specific areas (e.g., oncology, cardiology) |
- Enhances diagnostic accuracy and speed |
|
Physician Adoption and Workflow Integration |
- Physician usage trends |
- 66% physician adoption in 2024 (78% ↑ from 2023) |
- Boosts workflow efficiency |
|
Emerging Technologies and Future Applications |
- Multi-modal diagnostic systems |
- Systems integrate imaging, symptoms, labs for real-time diagnosis |
- Enables early diagnosis and preventive strategies |
3. AI-Driven Medicine Dispensing and Pharmacy Automation
3.1 Market Growth and Technology Adoption [16, 17]
The pharmacy automation market has experienced substantial growth during 2023-2025, with global market projections indicating a compound annual growth rate (CAGR) of 10.12% through 2034. The automated dispensing machines market specifically is expected to reach $6.22 billion by 2029, driven by technological advancements and an aging population requiring more complex medication management. This growth reflects the healthcare industry's recognition of automation's potential to address critical challenges including medication errors, operational efficiency, and pharmacist workload management. AI-powered systems are increasingly integrated into pharmacy operations, providing sophisticated capabilities for prescription processing, inventory management, and patient safety monitoring.
3.2 Smart Pharmacy Technologies [18-24]
The concept of "smart pharmacies" has emerged as a central theme in pharmacy automation during this period. These facilities integrate multiple AI technologies including robotics, computer vision, and predictive analytics to create comprehensive automated dispensing systems. Key innovations include:
Robotic Dispensing Systems: Advanced robotic systems now handle medication selection, packaging, and dispensing with unprecedented accuracy and speed. These systems can process prescriptions significantly faster than traditional methods while reducing human error rates.
Fig. 1: Automated medication dispensing system with computer by the Initiation of Artificial Intelligence
Source: https://healthmanagement.org/products/view/automated-medication-dispensing-system-with-computer-kl60-kirbylester
AI-Powered Inventory Management: Machine learning algorithms optimize medication inventory by predicting demand patterns, identifying slow-moving stock, and automating reorder processes. This capability is particularly valuable in managing specialty medications and reducing waste.
Eliška Nováková, Lejla Hadži?, Lars Janssens, Aaron Dogba Yassah, Faith Ruth Dixon, Clerick Clemento Conneh, Priojit Ghosh, Subham Kumar Lohani, Ayush Kumar, Sajid Ansari, Alok Kumar, Ankit Kumar Srivastava, Madhu Vishwakarma, Kajal Kumari, Arnab Roy*, Souradeep Sarkar, AI-Driven Disease Diagnosis and Medicine Dispensing: A New Era in Healthcare, Int. J. Sci. R. Tech., 2025, 2 (6), 296-305. https://doi.org/10.5281/zenodo.15612466
10.5281/zenodo.15612466